- Chemistry of thyroid hormones:
- Active isomer -- levo
(L-form) -- thyroxine, triiodothyronine,
reversed iodothyronine (reverse T4)
{dextro (D) form: about 4% of the
activity of the L form
return
to main menu
- Pharmacokinetics:
- T4
-- well absorbed from the ileum and
duodenum following oral administration--
about 80% absorbed on average
- Modification of
absorption:
- food
- drugs
(e.g., sucralfate, iron,
aluminum-containing antacids)
- T3
-- almost completely absorbed (95%)
following oral administration
- T4
and T3
absorption may be impaired by myxedema
with ileus (may require parenteral
administration {IV}, as a result)
- Factors that alter
T4 and T3 clearance:
- hyperthyroidism:
increases
- hypothyroidism:
decreases
- Drugs
(hepatic microsomal enzymes
inducers): Clearance is
enhanced;Euthyroid state may
be maintained because of thyroid hyperfunction.
- phenobarbital
- carbamazepine
- phenytoin
- rifampin
- Increases in the number of
TBG binding sites (due to pregnancy,
estrogen use, oral contraceptive use)
- more thyroid
hormone is bound; elimination
rate declines (only free
hormone can be eliminated);
normal hormone concentration
would be eventually restored
return
to main menu
- Mechanism of Hormone Action:
- Unbound T4 and T3
diffuse into the cell (passive diffusion,
possibly active transport)
- Inside cell:
- T4
T3
by 5'-deiodinase
- T3
cell
nucleus where T3 binds
to a specific T3
nuclear receptor
- Receptor:
- Two
classes of receptors, TRa TRb
:
- multiple
isoforms (as a result of
alternative splicing)
- homologous with
the c-erb oncogene family
- c-erb
(cellular
(c) homologues of the
avian retroviral v-erb A proto-oncogene.)
- c-erb
-A-a (TRa
)
- c-erb
-B-b
(TRb
)
- TR genes encode
for:
- T3
binding domain
- DNA-binding
domain which attaches
to regulatory DNA
sequences in genes with T3
regulated transcription
(growth hormone genes,
prolactin genes, TSH
genes)
- Activation
and modulation of
transcription rates are
mediated by thyroid
response elements (TREs--
regulatory sequences)
- T3
-TR combined with
auxiliary thyroid
receptor proteins (TRAPs)
interact with TREs to,
for example:
- c-erb
oncogene family includes:
- steroid
hormone receptors
- vitamin
A and D receptors
- Tissue to
tissue variation in
response may be due to
different concentration
of thyroid receptor forms
space for (T3
exists in two molecular
forms)
return
to main menu
- Thyroid hormones: metabolic actions
- nuclear receptor
activation increased RNA and protein synthesis: examples
--
- increased Na/K
ATPase increased ATP turnover,
increased oxygen consumption --calorigenic
effect
Thyroid
Hormone Effects*
Physiological
system
|
Hyperthyroidism
(thyrotoxicosis)
|
Hypothyroidism
|
skin
--appendages
|
warm,
moist skin; sweating; fine,
thin hair; Plumber's nails; pretibial dermopathy
(Graves' disease)
|
pale,
cool, puffy skin; brittle
hair and nails
|
Eyes,
face
|
Upper
lid retraction (wide stare);
periorbital edema; exophthalmos, diplopia
(Graves' disease)
|
Eyelid
drooping; periorbital edema;
puffy, nonpitting facies; large tongue
|
Cardiovascular
|
decreased
peripheral resistance, increased cardiac output,
stroke volume, heart rate, pulse pressure;
congestive heart failure (high-output); increased
contractility,. arrhythmogenic; angina
|
increased
peripheral resistance, decreased cardiac output,
stroke volume, heart rate, pulse pressure;
congestive heart failure (low output);
bradycardia (low voltage ECG with prolonged PR
interval, flat T wave); pericardial effusion
|
Respiratory
|
dyspnea;
reduced vital capacity
|
hypoventilation
(CO2
retention) pleural effusions
|
Gastrointestinal
|
increased
appetite; increased bowel movement frequency;
hypoproteinemia
|
decreased
appetite, decreased bowel movement frequency;
ascites
|
CNS
|
Nervousness,
hyperkinesia, variable emotional
states
|
lethargy,
neuropathy
|
Musculoskeletal
|
Weakness;
fatigue; hypercalcemia, osteoporosis,
increased deep tendon reflex
|
muscle
fatigue, reduced deep tendon
reflex, increased alkaline phosphatase, LDH, AST
|
Renal
|
Increased
renal blood flow; increased GFR;
mild polyuria
|
Decreased
renal blood flow; decreased GFR;
reduced water excretion
|
Hematopoietic
|
anemia
(increased RBC turnover);
increased erythropoiesis
|
anemia
(decrease production rate, decreased iron
absorption, decreased folate acid absorption,
autoimmune pernicious anemia),decreased
erythropoiesis
|
Reproductive
|
decreased
fertility; menstrual
irregularity; enhanced gonadal steroid metabolism
|
infertility;hypermenorrhea,
decreased libido; impotence, decreased gonadal
steroid metabolism
|
Metabolic
|
increased
basal rate; negative nitrogen balance,
hyperglycemia; increased free fatty acids, decreased
cholesterol and triglycerides; increased hormone degradation;
increased requirement for fat-and water-soluble
vitamins; enhanced drug
detoxification
|
decreased
basal rate; delayed insulin
degradation, with increased sensitivity; enhanced
cholesterol and triglyceride levels; decreased
hormone degradation;
decreased requirements for fat-and water-soluble
vitamins; decreased drug
detoxification.
|
|